Antioxidant Effect of Aged Garlic Extract
A Randomized, Double-blind, Placebo Controlled, Crossover Study to Evaluate the Antioxidant Effect of Aged Garlic Extract in Heavy Smokers
1 other identifier
interventional
60
1 country
1
Brief Summary
This is a randomized, double-blind, placebo controlled, crossover study to determine the antioxidant effect of aged garlic extract. This study will also compare the oxidative status in heavy smokers with that in non-smokers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2013
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2013
CompletedFirst Submitted
Initial submission to the registry
December 18, 2013
CompletedFirst Posted
Study publicly available on registry
December 24, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2015
CompletedAugust 19, 2015
August 1, 2015
1.4 years
December 18, 2013
August 17, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
Urinary 8-hydroxydeoxyguanosine (8-OHdG)
Every 4 weeks (Overall 12 weeks)
Secondary Outcomes (3)
High sensitive CRP
Every 4 weeks (Overall 12 weeks)
Blood pressure
Every 4 weeks (Overall 12 weeks)
Indices of the second derivative of photoplethysmogram (SDPTG)
Every 4 weeks (Overall 12 weeks)
Study Arms (3)
Placebo
PLACEBO COMPARATORSmoker subjects take 6 capsules once a day for 4 weeks.
Aged garlic extract
EXPERIMENTALSmoker subjects take 1.5 g of aged garlic extract in 6 capsules once a day for 4 weeks.
Non-smoker
NO INTERVENTIONOxidative status in non-smoker
Interventions
Eligibility Criteria
You may qualify if:
- Smoking (at least 20 cigarettes per day) or non-smoking (more than 20 years)
You may not qualify if:
- Under medication for chronic disease
- Garlic allergy
- Engaging in vigorous exercise
- Taking drugs or functional food that may possess antioxidant property
- Participation in any clinical trial within 90 days of the commencement of the trial
- Renal or hepatic dysfunction
- Heart disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Hiroshima Universitylead
- Wakunaga Pharmaceutical Co., Ltd.collaborator
Study Sites (1)
Hiroshima University
Hiroshima, Hiroshima, 734-8551, Japan
Study Officials
- PRINCIPAL INVESTIGATOR
Fumiko Higashikawa, PhD
Hiroshima University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
December 18, 2013
First Posted
December 24, 2013
Study Start
November 1, 2013
Primary Completion
April 1, 2015
Study Completion
April 1, 2015
Last Updated
August 19, 2015
Record last verified: 2015-08